Tacrine in Alzheimer's disease

Abstract The efficacy and safety of tacrine (tetrahydroaminoacridine) plus lecithin were studied in a randomised, double-blind, placebo-controlled, crossover study. Patients with probable Alzheimer's disease were selected from those attending the memory clinic at a psychiatric hospital. Of the 89 patients included, 24 were withdrawn, 1 9 because of side-effects, 4 with other illnesses, and 1 for non-compliance. The active treatment was the maximum tolerated dose of tacrine up to 150 mg daily plus 10·8 g lecithin daily. Patients were randomly assigned to active or placebo treatment and crossed over after 13 weeks' treatment and 4 weeks' washout to the other treatment. The main outcome measures were the mini mental state examination (MMSE), the abbreviated mental test score (AMTS), and the carer's rating of the activities of daily living scale. Analysis for the 65 patients who completed the trial showed a significant beneficial effect of tacrine over placebo in the MMSE score (p

[1]  D. Wechsler.  Manual for the Wechsler Adult Intelligence Scale. , 1955 .

[2]  Götz Kersting,et al.  Tests for symmetry , 1977 .

[3]  M. Hills,et al.  The two-period cross-over clinical trial. , 1979, British journal of clinical pharmacology.

[4]  M. Philpot,et al.  A memory clinic for the early diagnosis of dementia , 1987 .

[5]  E. Perry.  The cholinergic hypothesis--ten years on. , 1986, British medical bulletin.

[6]  M. Roth,et al.  The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.

[7]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[8]  J T O'Brien,et al.  Effects of tetrahydroaminoacridine on liver function in patients with Alzheimer's disease. , 1991, Age and ageing.

[9]  T. Robbins,et al.  Sparing of attentional relative to mnemonic function in a subgroup of patients with dementia of the Alzheimer type , 1990, Neuropsychologia.

[10]  H. Hodkinson.  Evaluation of a mental test score for assessment of mental impairment in the elderly. , 1972, Age and ageing.

[11]  P. Gibson,et al.  Heterogeneity of adverse hepatic reactions to tetrahydroaminoacridine. , 1990, Australian and New Zealand journal of medicine.

[12]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[13]  G. Chatellier,et al.  Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine. , 1990, BMJ.

[14]  F. Huppert,et al.  CAMDEX: A Standardised Instrument for the Diagnosis of Mental Disorder in the Elderly with Special Reference to the Early Detection of Dementia , 1986, British Journal of Psychiatry.

[15]  J. Danby,et al.  General practice obstetrics in Bradford , 1990, BMJ.

[16]  K. Davis,et al.  A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.

[17]  D. Pessayre,et al.  Acute hepatitis after tetrahydroaminoacridine administration for Alzheimer's disease. , 1990, Journal of clinical gastroenterology.

[18]  A. Kling,et al.  Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. , 1986, The New England journal of medicine.

[19]  T. Robbins,et al.  A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. , 1988, Brain : a journal of neurology.

[20]  J T Becker,et al.  Neuropsychological function in Alzheimer's disease. Pattern of impairment and rates of progression. , 1988, Archives of neurology.

[21]  M. Israël,et al.  Application to Mammalian Tissues of the Chemiluminescent Method for Detecting Acetylcholine , 1982, Journal of neurochemistry.

[22]  S. Gauthier,et al.  Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study. , 1990, The New England journal of medicine.

[23]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[24]  Nicola Morant,et al.  Parallel Group Analysis of the Effects of Tacrine versus Placebo in Alzheimer's Disease , 1991 .

[25]  M. Lawton,et al.  Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living , 1969 .

[26]  L. Thal,et al.  Longitudinal evaluation of dementia of the Alzheimer type , 1990, Neurology.